Dr Daniel Hodson

June 16, 2020

Daniel’s group researches the molecular mechanisms that underlie lymphomagenesis. He also holds an honorary consultant contract in the Haematology Department at Addenbrooke’s Hospital. Dan is also the Clinical Investigator for DIRECT (B-Cell Lymphoma trial).

 

Dr Daniel Hodson
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect